Kemper Corporation Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
National class action firm offering free case evaluations to individuals impacted by the Kemper Corporation cybersecurity incident NEWTOWN, Pa., April 21, 2026 /PRNewswire/... Read more.
Kemper Corporation Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
National class action firm offering free case evaluations to individuals impacted by the Kemper Corporation cybersecurity incident NEWTOWN, Pa., April 21, 2026 /PRNewswire/... Read more.
Georgia Heritage Financial Credit Union Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
National class action firm offering free case evaluations to individuals impacted by the Georgia Heritage Financial Credit Union cybersecurity incident SAVANNAH,... Read more.
Ampace Spotlights AI-Ready Battery Solutions for Gigascale Infrastructure at DCW Washington 2026
WASHINGTON, April 21, 2026 /PRNewswire/ — Ampace, a global leader in advanced lithium-ion battery technology, is participating in Data Center World 2026 at... Read more.
Georgia Heritage Financial Credit Union Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
National class action firm offering free case evaluations to individuals impacted by the Georgia Heritage Financial Credit Union cybersecurity incident SAVANNAH,... Read more.
Dayspring Pharma Announces Phase II Trial of CG2001 Foam Met Primary Endpoint in Chinese Adult Men with AGA
BEIJING, April 21, 2026 /PRNewswire/ — Dayspring Pharma today announced top-line data from its Phase II clinical trial of CG2001 foam in male patients with... Read more.
Ractigen Therapeutics Presents Positive Phase I Data for RAG-17 in SOD1-ALS at the 2026 AAN Annual Meeting, Demonstrating 81% Reduction in Neurofilament Light Chain
— Single intrathecal dose of SCAD-siRNA therapeutic RAG-17 yields favorable safety profile and profound, durable biomarker reductions —— Preliminary data from... Read more.
Case Report of Mabwell’s Nectin-4 targeting ADC (9MW2821) in Cervical Cancer Published in The New England Journal of Medicine
SHANGHAI, April 21, 2026 /PRNewswire/ — Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industrial chain, announced... Read more.
Nektar Therapeutics Announces Pricing of Upsized $325 Million Public Offering
SAN FRANCISCO, April 21, 2026 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative... Read more.
Trading Technologies and Mercantile Exchange of Vietnam Agree to Offer MXV Members Access to Global Derivatives Markets Through TT® Infrastructure
CHICAGO and HANOI, Vietnam, April 21, 2026 /PRNewswire/ — Trading Technologies International, Inc. (TT), a global capital markets technology platform services... Read more.